Karl Landsteiner University of Health Sciences important study center. Data published in New England Journal of Medicine. Krems (Austria), 23. November 2023: Results from a recently published phase II clinical trial of an immunotherapeutic agent (Tarlatamab) for the treatment of small cell lung cancer have demo.
Research Team at the Karl Landsteiner University of Health Sciences develops novel protocol for studying isolated pairs of hippocampal neurons. Dedicated work honoured by cover page in Bio-protocol Journal. Krems (Austria), 29. August 2023 – Studying the complex interactions between synaptic nerve endings.
From Chimney to Chimney: Successful Adsorber Technology for Clean Industrial Emission Now Also Available in Mobile Unit einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
A validation study by The University of Texas Southwestern (UTSW) Medical Center in Dallas confirms the advantages of an artificial intelligence software by ImageBiopsy Lab as part of the standard diagnosis of hip dysplasia - High reliability of AI bas.
An international team led by a physician from the Karl Landsteiner University for Health Sciences, Krems, describes for the first time a mutation of the IL-33 gene in the human genome that results in multiple allergic disease manifestations, and autoimmune disease. Krems (Austria), May 24th, 2022: Inflammation.